       Document 0208
 DOCN  M9620208
 TI    [Cytomegalovirus infection in HIV]
 DT    9602
 AU    Ferone U; Cerimele C; Isceri L; Trinchieri V; Proietti F; Galati V;
       Monacelli M; Istituto di Malattie Infettive, Universita degli Studi La;
       Sapienza, Roma.
 SO    Riv Eur Sci Med Farmacol. 1994 May-Aug;16(3-4):55-60. Unique Identifier
       : AIDSLINE MED/96005587
 AB    The data are taken from a retrospective study of 24 patients with AIDS
       who developed CMV disease. This study was performed to detect the
       principal characteristics associated with the development of CMV
       disease. Age, sex, risk factors, the time interval between HIV
       seropositivity to CMV disease were examined, as well as efficacy of
       gancyclovir therapy in both groups of patients with symptomatic and
       asymptomatic retinitis. When the chorioretinitis is still asymptomatic
       the early treatment of CMV disease may suppress progression of retinic
       lesions and seems to be efficacious to prevent the evolution of CMV
       disease.
 DE    Acquired Immunodeficiency Syndrome/*COMPLICATIONS/DRUG THERAPY  Adult
       Antiviral Agents/THERAPEUTIC USE  *AIDS-Related Opportunistic
       Infections/DRUG THERAPY  Cytomegalovirus Retinitis/DRUG
       THERAPY/*ETIOLOGY  English Abstract  Female  Ganciclovir/THERAPEUTIC USE
       Human  *HIV-1  Male  Middle Age  Retrospective Studies  CLINICAL TRIAL
       JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

